Until now the standard was surgery, but it seems we are entering a new era where surgery could be avoided, says oncologist ...

Two of the world’s biggest drugmakers — AstraZeneca and MSD — have hailed progress in tackling hard-to-treat cancers, ...

Speakers at the 2024 World Conference on Lung Cancer discussed the considerations that must go into designing and performing ...

Researchers have unveiled a potential paradigm shift in treatment strategies that could significantly improve patients' ...

From combining treatments in unprecedented ways to deploying artificial intelligence for personalised medicine, a raft of new ...

The surge in global cancer cases is raising serious concerns among experts. A recent study published in Monday in Cancer, a ...

Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of cancer-related deaths worldwide ...

Median duration of response reaches 7.4 months with combination treatment in patients with aggressive form of disease1 New results show potential of amivantamab beyond lung cancer1 BEERSE, BELGIUM, ...

A team of researchers at the University of Alberta has found that digoxin, a drug widely used to treat congestive heart ...

Educational event for physicians by physicians; participants heard from an esteemed panel of experts, innovators, and guest speakers - - Global medtech leaders, Siemens Healthineers and Cook Medical, ...

HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Sept. 19, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the Company , Stock Code: 2257 ...